Nano Precision Medical Inc

🤖 AI-Optimized Summary

NPM-139 is a miniature, subdermal, semaglutide drug implant with once or twice-yearly dosing under development for chronic weight management in patients who are obese or overweight. This implant can be conveniently inserted under the skin during a quick outpatient procedure and is designed to provide steady doses of medication. Based on positive preclinical weight loss data, NPM-139 is now planned for clinical development. NPM-115, a miniature, six-month, subdermal, subdermal, exenatide implant,

📋 Business Details